- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01161732
Early Surgery Versus Conventional Treatment in Very Severe Aortic Stenosis (RECOVERY)
May 1, 2019 updated by: Duk-Hyun Kang, Asan Medical Center
Randomized Comparison of Early Surgery Versus Conventional Treatment in Very Severe Aortic Stenosis
The optimal timing of surgical intervention remains controversial in asymptomatic patients with very severe aortic stenosis.
The investigators therefore try to compare long-term clinical outcomes of early surgery with those of conventional treatment strategy in a prospective randomized trial.
Study Overview
Detailed Description
Management of asymptomatic patients with severe aortic stenosis (AS) remains controversial, and the combined risks of aortic valve surgery and late complications of aortic valve prosthesis need to be balanced against the possibility of preventing sudden death and lowering cardiac mortality.
Considering that sudden cardiac death occurs at a rate of approximately 1% per year and that the average postoperative mortality of isolated AV replacement is 3.0-4.0%,
the 2007 European Society of Cardiology guidelines do not recommend aortic valve surgery for asymptomatic patients with severe AS and the 2006 American College of Cardiology/American Heart Association guidelines recommend surgery as a class IIb indication only in patients with extremely severe AS and who are at low operative risk.
Clinical outcomes vary widely according to the severity of stenosis in asymptomatic AS, and asymptomatic patients with very severe AS are often referred for aortic valve replacement in clinical practice despite the lack of data supporting early surgery.
Rosenhek et al recently reported a worse prognosis with a higher event rate and a risk of rapid deterioration in very severe AS, and the investigators also recently reported that compared with the conventional treatment strategy, early surgery in patients with very severe AS is associated with an improved long-term survival in a prospective, observational study.
However, there have been no prospective,randomized studies comparing early surgery with a watchful waiting strategy in very severe AS.
We sought to compare long-term clinical outcomes of early surgery with those of conventional management based on current guidelines.
Study Type
Interventional
Enrollment (Actual)
145
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
Seoul, Korea, Republic of, 135-710
- Samsung Medical Center
-
Seoul, Korea, Republic of, 138-736
- Asan Medical Center
-
Seoul, Korea, Republic of
- Yonsei University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- asymptomatic patients with very severe aortic stenosis who are potential candidates for early surgery. Very severe aortic stenosis are defined as a critical stenosis in the AV area ≤ 0.75 square centimeter fulfilling one of the following criteria; a peak aortic velocity ≥ 4.5 m/sec or a mean transaortic pressure gradient ≥ 50 mmHg on Doppler echocardiography.
According to the revised 2014 AHA/ACC Valvular Heart Disease Guideline that recommends exercise testing to confirm the absence of symptoms in asymptomatic patients with severe AS (Class IIa), eligible patients with a positive exercise test will be excluded from the entry after May, 2014.
Exclusion Criteria:
- Exertional dyspnea
- Angina
- Syncope
- Left ventricular ejection fraction < 50%
- Significant aortic regurgitation
- Significant mitral valve disease
- Pregnancy
- Age < 20 years or > 80 years
- Coexisting malignancies
- Positive exercise test
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Conventional treatment
In the conventional treatment group, indications for aortic valve replacement surgery are development of symptoms, reduced left ventricular systolic function and an increase in aortic jet velocity > 0.5 m/sec during follow-up.
|
|
ACTIVE_COMPARATOR: Early Surgery
Early surgery is performed within 2 months of randomization.
|
Early surgery is performed within 2 months of randomization.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac mortality
Time Frame: Entire follow-up ( a minimum of 4 years)
|
defined as death from complications of myocardial infarction, heart failure, shock, complications of cardiac surgery or intervention, other cardiovascular diseases including sudden cardiac death
|
Entire follow-up ( a minimum of 4 years)
|
Operative mortality
Time Frame: up to 30 days after surgery
|
Operative mortality is defined as death within 30 days of surgery.
|
up to 30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause death
Time Frame: Entire follow-up (a minimum of 4 years)
|
Entire follow-up (a minimum of 4 years)
|
|
Repeat aortic valve surgery
Time Frame: Entire follow-up (a minimum of 4 years)
|
Entire follow-up (a minimum of 4 years)
|
|
Clinical thromboembolic events
Time Frame: Entire follow-up (a minimum of 4 years)
|
Diagnosis of thromboembolic events is based on clinical symptoms, signs and imaging studies.
|
Entire follow-up (a minimum of 4 years)
|
Hospitalization due to congestive heart failure
Time Frame: Entire follow-up (a minimum of 4 years)
|
A hospitalization due to congestive heart failure is defined as an unplanned, urgent admission for the management of congestive heart failure.
|
Entire follow-up (a minimum of 4 years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Duk-Hyun Kang, M.D., Division of Cardiology, Asan Medical Center, University of Ulsan, College of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kang DH, Park SJ, Rim JH, Yun SC, Kim DH, Song JM, Choo SJ, Park SW, Song JK, Lee JW, Park PW. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation. 2010 Apr 6;121(13):1502-9. doi: 10.1161/CIRCULATIONAHA.109.909903. Epub 2010 Mar 22.
- Park SJ, Lee S, Lee SA, Kim DH, Kim HK, Hong GR, Song JM, Chung CH, Park SW, Kang DH. Impact of Early Surgery and Staging Classification on Survival in Asymptomatic Very Severe Aortic Stenosis. J Am Coll Cardiol. 2021 Feb 2;77(4):506-508. doi: 10.1016/j.jacc.2020.11.045. No abstract available.
- Kang DH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK, Yun SC, Hong GR, Song JM, Chung CH, Song JK, Lee JW, Park SW. Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. N Engl J Med. 2020 Jan 9;382(2):111-119. doi: 10.1056/NEJMoa1912846. Epub 2019 Nov 16.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2010
Primary Completion (ACTUAL)
April 30, 2019
Study Completion (ACTUAL)
April 30, 2019
Study Registration Dates
First Submitted
July 12, 2010
First Submitted That Met QC Criteria
July 13, 2010
First Posted (ESTIMATE)
July 14, 2010
Study Record Updates
Last Update Posted (ACTUAL)
May 3, 2019
Last Update Submitted That Met QC Criteria
May 1, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-0065
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Stenosis
-
Abbott Medical DevicesActive, not recruitingSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
Hospices Civils de LyonRecruiting
-
Edwards LifesciencesActive, not recruitingAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Anteris Technologies Ltd.Active, not recruitingAortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisGeorgia
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
Ningbo Jenscare Biotechnology Co., Ltd.UnknownAortic Regurgitation | Severe Aortic Stenosis
-
Edwards LifesciencesCompletedAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Genesis Medtech CorporationRecruitingDiseases of Aortic Valve | Aortic Stenosis DiseaseChina
-
Saint Petersburg State University, RussiaNot yet recruitingIschemic Heart Disease | Mitral Insufficiency | Aortic Stenosis, Severe | Mitral Stenosis | Aortic Insufficiency | Ascending Aortic Aneurysm | Mitral Stenosis With Insufficiency | Tricuspid InsufficiencyRussian Federation
-
Pan XiangbinRecruiting
Clinical Trials on Early surgery
-
University of PittsburghMayo Clinic; University of Missouri-Columbia; Washington University School of... and other collaboratorsRecruitingKnee Dislocations | Multiple Ligament Knee InjuriesUnited States
-
Tokyo UniversityCompleted
-
Glostrup University Hospital, CopenhagenCompleted
-
Centre Hospitalier Universitaire de NiceTerminatedObesity | Chronic Kidney DiseaseFrance
-
Asan Medical CenterActive, not recruitingMitral RegurgitationKorea, Republic of
-
Maria Vittoria HospitalMinistry of Health, ItalyTerminated
-
Asan Medical CenterCompletedEndocarditisKorea, Republic of
-
Diakonhjemmet HospitalThe Norwegian Women´s Public Health AssociationUnknown
-
The Hospital for Sick ChildrenMcMaster University; Institute for Clinical Evaluative SciencesCompletedSurgery in Early ChildhoodCanada